Clinical Trial

Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

Name: Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures — clinical trial record (NCT07505004)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: POWER2

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A multicenter, double-blind, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of vormatrigine in adults with focal seizures (POWER2)

Protocol Amendment History 1 change

critical Enrollment closed, study ongoing 2026-08-04

Trial Details

NCT Number	NCT07505004
Lead Sponsor	Praxis Precision Medicines
Conditions	Focal Epilepsy
Enrollment	300 participants
Start Date	2026-01-29
Primary Completion	2027-01 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-03